-
Trifluoperazine 2HCl: From D2 Signaling to Host Defense
2026-08-24
Trifluoperazine 2HCl offers translational researchers a target-defined entry point into dopamine D2 receptor biology and a testable bridge to phenothiazine-mediated macrophage defense. This thought-leadership analysis connects dopaminergic signaling pathway modulation with ROS, autophagy, assay strategy, and host-directed therapeutic development.
-
BHQ for Calcium Signaling Research
2026-08-24
Use 2,5-di-tert-butylbenzene-1,4-diol (BHQ) to create a controllable SERCA-dependent calcium perturbation for ER, vascular, and hematopoietic studies. A practical workflow links calcium imaging and molecular validation with the emerging HSC mobilization mechanism reported in 2025.
-
Reparixin: Mapping the IL-8–CXCR1/2 Axis
2026-08-23
A translational framework for using Reparixin as a mechanistic CXCR1/2 inhibitor to test how IL-8 signaling connects antibiotic-resistant bacterial vesicles, tumor growth, neutrophil biology, and tissue injury.
-
Syringin: An Assay-First Guide to RCC Research
2026-08-22
Syringin natural product research is moving from phenotypic screening toward mechanism-aware assay design. This guide connects compound identity, EGFR/PI3K/Akt signaling, apoptosis research, and sunitinib-response experiments while defining the evidence boundaries for rigorous RCC studies.
-
Phosphatase Inhibitor Cocktail 1: Practical Protocol
2026-08-22
Phosphatase Inhibitor Cocktail 1 (100X in DMSO) helps limit endogenous alkaline and serine/threonine phosphatase activity during cell or tissue sample preparation, supporting more reliable phosphorylation-state measurements. It is intended for research workflows such as immunoblotting, immunoprecipitation, phosphoproteomic analysis, and kinase assays, but it is not a diagnostic or medical reagent.
-
Sodium Citrate: A SERS Assay Decision Guide
2026-08-21
Sodium citrate is more than a routine buffer in biochemical research: its chelation, pH-control, and compatibility profile can shape how SERS workflows are designed and interpreted. This guide separates documented nanofabrication findings from practical assay recommendations for more defensible decisions.
-
Berberrubine Chloride: A Mechanistic Assay Guide
2026-08-20
Berberrubine chloride is a multi-target research compound linking nucleotide metabolism, redox control, urate transport, and inflammatory signaling. This mechanistic assay guide explains how to distinguish direct target engagement from downstream phenotypes in cancer and hyperuricemia models.
-
DHHC9–STRN4 Palmitoylation Drives YAP Metastasis
2026-08-20
A 2025 study identifies DHHC9-mediated palmitoylation of STRN4 as a mechanistic trigger for YAP activation and adenocarcinoma migration. Its genetic, proteomic, and pharmacological evidence positions the DHHC9–STRN4–YAP axis as a candidate framework for anti-metastatic drug discovery, while requiring further validation of inhibitor selectivity and clinical relevance.
-
Ethacridine Lactate Monohydrate for Research
2026-08-19
Ethacridine lactate monohydrate is a ≥98% pure acridine-derived antiseptic research compound identified as 7-ethoxyacridine-3,9-diamine; 2-hydroxypropanoic acid; hydrate. Its documented product profile supports microbial-control assay development, while the cited YAP–TEAD study provides biological context but does not establish ethacridine as a regulator of surface ectoderm differentiation.
-
Merbromin Inhibits SARS-CoV-2 3CLpro
2026-08-19
The reference study identified merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease, 3CLpro, through screening of approximately 6,000 compounds. Its combination of enzymatic screening, protease counterscreening, kinetic analysis, binding assays, and molecular docking provides a useful framework for evaluating antiviral protease inhibitors while also highlighting the need for cellular and pharmacological validation.
-
NF 449 and Platelet P2X1 Receptor Inhibition
2026-08-18
The reference study established NF 449 as a useful pharmacological probe for separating platelet P2X1 signaling from P2Y1- and P2Y12-mediated responses. By combining human platelet assays with mouse thrombosis models, the authors linked P2X1 blockade to reduced collagen-driven activation and thrombus formation while showing that dose determines receptor selectivity.
-
SD 169: p38 MAPK Assay Workflows
2026-08-18
SD 169 (indole-5-carboxamide) gives researchers a practical way to interrogate p38α/β signaling across inflammatory, beta-cell, and nerve-repair models. This guide pairs pathway-focused assay design with handling, dosing, and troubleshooting strategies for more interpretable data.
-
Hesperadin: Aurora B Kinase Inhibitor Guide
2026-08-17
Hesperadin is an ATP-competitive Aurora B kinase inhibitor used to investigate mitotic progression, chromosome segregation, cytokinesis, and spindle assembly checkpoint biology. Product data report nanomolar Aurora B and histone H3 Ser-10 inhibition, while HeLa-cell studies show proliferation arrest, enlarged lobed nuclei, and polyploidization.
-
HBsAg Hijacks TBK1 to Suppress Interferon and Autophagy
2026-08-17
The reference study identifies a mechanism in which hepatitis B surface antigen redirects TBK1 activity away from IRF3 and toward p62-associated autophagy, weakening type I interferon responses while supporting HBV replication. Its combination of molecular interaction studies, pharmacological perturbation, animal models, and human liver samples provides a useful framework for studying innate immune response modulation in chronic HBV infection.
-
Chlorpromazine: A Context-Aware Research Guide
2026-08-16
Chlorpromazine is a versatile tool for antipsychotic research, dopamine receptor signaling, and antiemetic studies. This guide adds a context-aware framework for connecting receptor pharmacology with hepatic nanoparticle assay design without overstating the evidence.